Home > Financial Ratios > ASPIRA PATHLAB & DIAGNOSTICS

ASPIRA PATHLAB & DIAGNOSTICS
Core EBITDA Margin

    Back to All Ratios
ASPIRA PATHLAB & DIAGNOSTICS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for ASPIRA PATHLAB & DIAGNOSTICS
Please provide your vote to see the results

ASPIRA PATHLAB & DIAGNOSTICS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024
   Core EBITDA Margin(%) 16.02-8.99

What is the latest Core EBITDA Margin ratio of ASPIRA PATHLAB & DIAGNOSTICS ?

The latest Core EBITDA Margin ratio of ASPIRA PATHLAB & DIAGNOSTICS is 16.02 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar202516.02
Mar2024-8.99

How is Core EBITDA Margin of ASPIRA PATHLAB & DIAGNOSTICS Trending?

Years Core EBITDA Margin % Change
Mar2025 16.02
Positive
Mar2024 -8.99 -

Other Financial Ratios of ASPIRA PATHLAB & DIAGNOSTICS


Compare Core EBITDA Margin ratio of peers of ASPIRA PATHLAB & DIAGNOSTICS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASPIRA PATHLAB & DIAGNOSTICS ₹133.9 Cr 7.7% 47.8% 102% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹127,823.0 Cr -0.6% 1.1% 14% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹98,693.7 Cr -4.7% 0.2% -9.8% Stock Analytics
ASTER DM HEALTHCARE ₹66,181.7 Cr 0.4% -0.4% 17.9% Stock Analytics
FORTIS HEALTHCARE ₹63,046.6 Cr -6.9% -9% -8% Stock Analytics
NARAYANA HRUDAYALAYA ₹38,040.7 Cr -1.8% -1.2% 5.6% Stock Analytics


ASPIRA PATHLAB & DIAGNOSTICS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASPIRA PATHLAB & DIAGNOSTICS

7.7%

47.8%

102%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses